메뉴 건너뛰기
JACC: Cardiovascular Interventions
Volumn 2, Issue 1, 2009, Pages 75-76
Sirolimus-Eluting Stents or Vascular Brachytherapy for In-Stent Restenosis After 3-Year Follow-Up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) Trial. A Call for Caution?
Author keywords

[No Author keywords available]
Indexed keywords

RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT;
EID: 58249102207     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.11.001     Document Type: Letter
Times cited : (4)
References (5)
  • 1
    • 49549111193 scopus 로고    scopus 로고
    • Three-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial
    • Holmes D., Teirstein P., Satler L., et al. Three-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial. J Am Coll Cardiol Intv 1 (2008) 439-448
    • (2008) J Am Coll Cardiol Intv , vol.1 , pp. 439-448
    • Holmes, D.1    Teirstein, P.2    Satler, L.3
  • 2
    • 33746751484 scopus 로고    scopus 로고
    • Myocardial infarction as a presentation of clinical in-stent restenosis
    • Nayak A.K., Kawamura A., Nesto R.W., et al. Myocardial infarction as a presentation of clinical in-stent restenosis. Circ J 70 (2006) 1026-1029
    • (2006) Circ J , vol.70 , pp. 1026-1029
    • Nayak, A.K.1    Kawamura, A.2    Nesto, R.W.3
  • 3
    • 0037438810 scopus 로고    scopus 로고
    • Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience
    • Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 41 (2003) 184-189
    • (2003) J Am Coll Cardiol , vol.41 , pp. 184-189
    • Degertekin, M.1    Regar, E.2    Tanabe, K.3
  • 4
    • 54049147297 scopus 로고    scopus 로고
    • Long-term safety and efficacy of percutaneous coronary interventions with stenting and coronary bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient level data from ARTS, ERACI-II, MASS-II, and SoS trials
    • Daemen J., Boersma E., Flather M., et al. Long-term safety and efficacy of percutaneous coronary interventions with stenting and coronary bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient level data from ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 118 (2008) 1146-1154
    • (2008) Circulation , vol.118 , pp. 1146-1154
    • Daemen, J.1    Boersma, E.2    Flather, M.3
  • 5
    • 34948816074 scopus 로고    scopus 로고
    • Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry
    • Rodriguez A.E., Maree A., Mieres J., et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 28 (2007) 2118-2125
    • (2007) Eur Heart J , vol.28 , pp. 2118-2125
    • Rodriguez, A.E.1    Maree, A.2    Mieres, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.